CLINICAL_TRIALS
trial_result
· 2024-05-10
Clinical Trial Update: Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP [Phase 1]
Summary
Phase 1 study reports safety, tolerability, and antimalarial activity of single doses of OZ439 and PQP in malaria; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2024-05-10